159 related articles for article (PubMed ID: 38366667)
1. Therapeutic targeting of cell transition: ready for clinical prime-time?
van der Vorst EPC; Kovacic JC
Cardiovasc Res; 2024 Apr; 120(5):e14-e16. PubMed ID: 38366667
[No Abstract] [Full Text] [Related]
2. An antibody against L1 cell adhesion molecule inhibits cardiotoxicity by regulating persistent DNA damage.
Nam JK; Kim AR; Choi SH; Kim JH; Choi KJ; Cho S; Lee JW; Cho HJ; Kwon YW; Cho J; Kim KS; Kim J; Lee HJ; Lee TS; Bae S; Hong HJ; Lee YJ
Nat Commun; 2021 Jun; 12(1):3279. PubMed ID: 34078883
[TBL] [Abstract][Full Text] [Related]
3. Silencing of c-Ski augments TGF-b1-induced epithelial-mesenchymal transition in cardiomyocyte H9C2 cells.
Ling J; Cai Z; Jin W; Zhuang X; Kan L; Wang F; Ye X
Cardiol J; 2019; 26(1):66-76. PubMed ID: 29570207
[TBL] [Abstract][Full Text] [Related]
4. Arsenite Disrupts Zinc-Dependent TGFβ2-SMAD Activity During Murine Cardiac Progenitor Cell Differentiation.
Huang T; Ditzel EJ; Perrera AB; Broka DM; Camenisch TD
Toxicol Sci; 2015 Dec; 148(2):409-20. PubMed ID: 26354774
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
Sun X; Sun Y; Jiang P; Qi G; Chen X
Biomed Pharmacother; 2020 Apr; 124():109822. PubMed ID: 31958767
[TBL] [Abstract][Full Text] [Related]
6. Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.
Begemann D; Anastos H; Kyprianou N
Int J Urol; 2018 Apr; 25(4):318-326. PubMed ID: 29345000
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis.
Xu X; Tan X; Tampe B; Nyamsuren G; Liu X; Maier LS; Sossalla S; Kalluri R; Zeisberg M; Hasenfuss G; Zeisberg EM
Cardiovasc Res; 2015 Mar; 105(3):279-91. PubMed ID: 25616414
[TBL] [Abstract][Full Text] [Related]
8. The origin and arrhythmogenic potential of fibroblasts in cardiac disease.
Vasquez C; Morley GE
J Cardiovasc Transl Res; 2012 Dec; 5(6):760-7. PubMed ID: 22987310
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition: a new target in anticancer drug discovery.
Marcucci F; Stassi G; De Maria R
Nat Rev Drug Discov; 2016 May; 15(5):311-25. PubMed ID: 26822829
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3.
Sharma V; Dogra N; Saikia UN; Khullar M
Can J Physiol Pharmacol; 2017 Oct; 95(10):1263-1270. PubMed ID: 28686848
[TBL] [Abstract][Full Text] [Related]
11. Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer.
Liu J; Chen X; Ward T; Mao Y; Bockhorn J; Liu X; Wang G; Pegram M; Shen K
Int J Biochem Cell Biol; 2016 Feb; 71():12-23. PubMed ID: 26643609
[TBL] [Abstract][Full Text] [Related]
12. Histamine prevents radiation-induced mesenchymal changes in breast cancer cells.
Galarza TE; Mohamad NA; Táquez Delgado MA; Vedoya GM; Crescenti EJ; Bergoc RM; Martín GA; Cricco GP
Pharmacol Res; 2016 Sep; 111():731-739. PubMed ID: 27473821
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNA in endothelial-to-mesenchymal transition.
Hulshoff MS; Del Monte-Nieto G; Kovacic J; Krenning G
Cardiovasc Res; 2019 Oct; 115(12):1716-1731. PubMed ID: 31504268
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method.
Zhang J; Klos M; Wilson GF; Herman AM; Lian X; Raval KK; Barron MR; Hou L; Soerens AG; Yu J; Palecek SP; Lyons GE; Thomson JA; Herron TJ; Jalife J; Kamp TJ
Circ Res; 2012 Oct; 111(9):1125-36. PubMed ID: 22912385
[TBL] [Abstract][Full Text] [Related]
15. Candesartan antagonizes pressure overload-evoked cardiac remodeling through Smad7 gene-dependent MMP-9 suppression.
Yu H; Zhao G; Li H; Liu X; Wang S
Gene; 2012 Apr; 497(2):301-6. PubMed ID: 22326534
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
Cho ES; Kang HE; Kim NH; Yook JI
Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
[TBL] [Abstract][Full Text] [Related]
17. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
Dong F; Liu T; Jin H; Wang W
Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
[TBL] [Abstract][Full Text] [Related]
18. Endothelial to Mesenchymal Transition in Cardiovascular Disease: JACC State-of-the-Art Review.
Kovacic JC; Dimmeler S; Harvey RP; Finkel T; Aikawa E; Krenning G; Baker AH
J Am Coll Cardiol; 2019 Jan; 73(2):190-209. PubMed ID: 30654892
[TBL] [Abstract][Full Text] [Related]
19. A promising field: regulating imbalance of EndMT in cardiovascular diseases.
Zhou K; Tian KJ; Yan BJ; Gui DD; Luo W; Ren Z; Wei DH; Liu LS; Jiang ZS
Cell Cycle; 2021 Aug; 20(15):1477-1486. PubMed ID: 34266366
[TBL] [Abstract][Full Text] [Related]
20. Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?
Martin ML; Blaxall BC
J Cardiovasc Transl Res; 2012 Dec; 5(6):768-82. PubMed ID: 23015462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
